The Rapid Review Panel (RRP) evaluates products for potential use in the NHS on the basis of:
- submitted scientific evidence to support claims of improved efficiency
- efficacy of infection prevention and control (IPC) interventions to reduce healthcare associated infections (HCAIs)
Products are voluntarily submitted for consideration. This document outlines the criteria used to evaluate them.